Drs Patrick Myers, David Taggart, and Michael Mack discuss the ORBITA trial, focusing on the importance of the sham-control design of the trial, ORBITA's context within previous and upcoming trials, and what the results mean for cardiac surgeons.
Comments (3)
More Episodes
All Episodes>>
Get this podcast on your phone, Free
Create Your Podcast In Minutes
- Full-featured podcast site
- Unlimited storage and bandwidth
- Comprehensive podcast stats
- Distribute to Apple Podcasts, Spotify, and more
- Make money with your podcast
It is Free
